Caseware UK (AP4) 2022.0.179 2022.0.179 2023-02-282023-02-282022-03-01trueNo description of principal activity11true 04355378 2022-03-01 2023-02-28 04355378 2021-03-01 2022-02-28 04355378 2023-02-28 04355378 2022-02-28 04355378 c:Director1 2022-03-01 2023-02-28 04355378 c:EntityHasNeverTraded 2022-03-01 2023-02-28 04355378 c:AuditExempt-NoAccountantsReport 2022-03-01 2023-02-28 04355378 c:FullAccounts 2022-03-01 2023-02-28 04355378 c:PrivateLimitedCompanyLtd 2022-03-01 2023-02-28 04355378 c:Micro-entities 2022-03-01 2023-02-28 iso4217:GBP xbrli:pure
Registered number: 04355378


OSTEOCARE INTERNATIONAL LIMITED
UNAUDITED
FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE YEAR ENDED 28 FEBRUARY 2023




 
OSTEOCARE INTERNATIONAL LIMITED
REGISTERED NUMBER: 04355378

BALANCE SHEET
AS AT 28 FEBRUARY 2023

2023
2022
£
£


Called up share capital not paid
2
2

Total assets less current liabilities
2
2


Net assets
2
2



Capital and reserves
2
2


Notes


General information

The company is a private limited company, having a share capital, registered in England and Wales, company
registration number 04355378. The registered office is situated at 1a High Street, Epsom, Surrey KT19 8DA.


Average number of employees

The average monthly number of employees, including directors, during the year was 1 (2022 - 1).

The Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

The members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 6 October 2023.






C A Gauld
Director

Page 1